Park Medi World Limited Q1 FY27 Investor Presentation: Growth and Acquisitions
Park Medi World Limited reported Q1 FY'27 revenue of ₹4,757 million, up 19% YoY. Net profit increased 35% YoY to ₹886 million. The company announced the acquisition of The Medicity Hospital in Rudrapur for ₹177 crore and a hospital in Zirakpur for ₹107 crore. Bed capacity reached 3,960, with plans to expand to 5,740 by March 2028.
The company is undertaking substantial strategic initiatives including major acquisitions and significant capacity expansion, which are expected to have a material impact on its future financial performance and market position.
The announcement details strong financial performance, significant capacity expansion through acquisitions and greenfield projects, and a clear growth strategy, all contributing to a positive outlook for the company.
Park Medi World Limited has released its Investor Presentation for the Financial Results for the quarter ended June 30, 2026. The presentation details the company's performance, growth strategies, and future outlook.
During the quarter, the company focused on consolidating its position and expanding its network. A significant development was the acquisition of 'The Medicity Hospital' in Rudrapur, a 330-bed facility, for ₹177 crore in an all-cash transaction, marking the company's entry into its sixth state. This hospital was commissioned on August 2, 2026. Additionally, a 100-bed extension at the Palam Vihar facility in Gurugram was announced, increasing its consolidated capacity to 750 beds. The company also announced the acquisition of a 150-bed hospital in Zirakpur for approximately ₹107 crore, also an all-cash transaction, expected to be consummated in November 2026.
As of June 30, 2026, Park Medi World's total bed capacity stood at 3,960 beds, a 32% increase year-on-year. The company anticipates capacity additions to reach 1,490 beds in calendar year 2026, a 46% increase over the calendar year 2025 base. Projections indicate an exit from FY'27 at 4,740 beds and reaching 5,740 beds by March 2028, funded primarily through internal accruals and IPO proceeds.
Financially, for Q1 FY'27, the company reported revenue of ₹4,757 million, a 19% year-on-year increase. EBITDA stood at ₹1,261 million, with an EBITDA margin of 26.5%. Net profit was ₹886 million, a 35% year-on-year increase, with a Net Profit Margin of 18.6%. The company highlighted strong financial and operating performance, with bed capacity and occupancy showing positive trends, though occupancy moderated due to new capacity additions.
The presentation also outlines the company's growth strategy, which involves a balanced mix of Greenfield, Brownfield, and strategic acquisitions, focusing on enhancing super-speciality capabilities. The company has a proven track record of integrating acquired hospitals, with 77% of its PAT and 65% of its revenue in Q1 FY'27 coming from acquired hospitals. The management emphasized a focus on integration, utilization improvement, and sustaining profitability while delivering affordable, high-quality healthcare.
What to do with a filing like this
Park Medi World Limited filed this with the NSE as a statutory disclosure, categorised under investor presentation. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Park Medi World Limited. Read the original for the full detail.